AMICUS THERAPEUTICS INC — Form D

AMICUS THERAPEUTICS INC of CRANBURY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2012-07-30. The offering totals $18.6M, of which $18.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (76)

Showing 25 of 76 people.

NameRoleLocation
Sol J. BarerDirectorCranbury, NJ
James J. BarrettDirectorCranbury, NJ
John F. CrowleyDirectorCranbury, NJ
Robert W. EssnerDirectorCranbury, NJ
Donald J. Hayden, Jr.DirectorCranbury, NJ
Ted W. LoveDirectorCranbury, NJ
Margaret G. McGlynnDirectorCranbury, NJ
Michael G. RaabDirectorCranbury, NJ
Glenn G. SblendorioDirectorCranbury, NJ
James N. TopperDirectorCranbury, NJ
William D. Baird, IIIExecutive OfficerCranbury, NJ
Pol F. BoudesExecutive OfficerCranbury, NJ
Bradley L. CampbellExecutive OfficerCranbury, NJ
John F. CrowleyExecutive OfficerCranbury, NJ
Enrique R. DiloneExecutive OfficerCranbury, NJ
John R. KirkExecutive OfficerCranbury, NJ
David J. LockhartExecutive OfficerCranbury, NJ
Kenneth W. PeistExecutive OfficerCranbury, NJ
Daphne W. QuimiExecutive OfficerCranbury, NJ
Ken R. ValenzanoExecutive OfficerCranbury, NJ
Robert W. WinklerExecutive OfficerCranbury, NJ
David ClarkExecutive OfficerLafayette, CO
Bradley CampbellDirectorTampa, FL
Bradley CampbellExecutive OfficerTampa, FL
John F CrowleyDirectorPrinceton, NJ

Other filings by this issuer (6)

FiledFormOfferingSold
2023-10-16D$30.0M$30.0M
2021-10-13D$199.9M$199.9M
2016-07-19D$4.7M$4.7M
2013-12-03D$15.0M$15.0M
2013-12-03D$15.0M$15.0M
2010-11-05D$31.3M$31.3M

More